Edinburgh-based Craneware, a provider of software for the US healthcare market, announced on Monday the refinancing of its banking facilities “providing increased flexibility to execute its growth strategy.”
The refinancing will operate alongside the firm’s recent, proposed “reduction of capital” which it said is expected to create “additional distributable reserves” of more than $284 million.
“The Group has renewed its Revolving Credit Facility (RCF) on improved terms, for a further three years, with the option to extend for two further one-year terms,” said Craneware.
“This new unsecured $100m RCF consolidates the previous term loan and RCF, is at lower interest rates than the previous facilities, and provides a further $100m accordion facility that could support potential M&A activities.
“The facilities have been provided by a consortium of HSBC, Barclays, NatWest and Santander.
“Alongside the Refinancing, the Board has initiated a proposed reduction of capital, as announced on 1 August 2025.
“This would create additional distributable reserves of $284.2m, if ultimately approved by the Court process, giving the Company further flexibility to deliver shareholder returns over the coming years, either in the form of distributions and/or purchases of the Company’s own shares.
“Following the approval of the resolutions to approve the proposed capital reduction on 20 August 2025, the first court hearing for initial direction is expected to be held shortly.
“In July 2025, the Group confirmed it had experienced positive trading throughout the fiscal year ended 30 June 2025, delivering continued strong revenue growth, and a double digit increase to profitability, ahead of prior expectations.
“The Group continued to deliver high levels of operating cash conversion, which have been invested in the product portfolio, and reducing debt, with total bank debt reduced to $27.7m at 30 June 2025 (FY24: $35.4m), whilst retaining healthy total cash reserves of $55.9m (FY24: $34.6m).
“The Group will announce audited Final Results for the year ended 30 June 2025 on 15 September 2025.”
Craneware CEO Keith Neilson said: “We would like to thank our banking partners for their continued support of the business and belief in our growth strategy.
“Our strategic position at the heart of the U.S. healthcare market, strong balance sheet and positive trading provides us with a strong position from which to explore multiple avenues for growth, as we support our customers in the transformation of the business of healthcare.”